ORTHO-NOVUM 1 Drug Patent Profile

When do Ortho-novum 1 patents expire, and when can generic versions of Ortho-novum 1 launch?

Ortho-novum 1 is a drug marketed by Ortho Mcneil Pharm, Janssen Pharms, and Ortho Mcneil Janssen. and is included in six NDAs.

The generic ingredient in ORTHO-NOVUM 1 is mestranol; norethindrone. There are eleven drug master file entries for this compound. Additional details are available on the mestranol; norethindrone profile page.

Summary for ORTHO-NOVUM 1

US Patents:	0
Applicants:	3
NDAs:	6
DailyMed Link:	ORTHO-NOVUM 1 at DailyMed

US Patents and Regulatory Information for ORTHO-NOVUM 1

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ortho Mcneil Pharm	ORTHO-NOVUM 10-21	mestranol; norethindrone	TABLET;ORAL-21	012728-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Ortho Mcneil Pharm	ORTHO-NOVUM 1/50 21	mestranol; norethindrone	TABLET;ORAL-21	012728-004	Approved Prior to Jan 1, 1982		DISCN	No	No
Ortho Mcneil Janssen	ORTHO-NOVUM 1/50 28	mestranol; norethindrone	TABLET;ORAL-28	016709-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Ortho Mcneil Pharm	ORTHO-NOVUM 1/80 28	mestranol; norethindrone	TABLET;ORAL-28	016715-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Ortho Mcneil Pharm	ORTHO-NOVUM 1/35-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	017489-002	Approved Prior to Jan 1, 1982		DISCN	No	No
Janssen Pharms	ORTHO-NOVUM 1/35-28	ethinyl estradiol; norethindrone	TABLET;ORAL-28	017919-002	Approved Prior to Jan 1, 1982		DISCN	Yes	No
Ortho Mcneil Janssen	ORTHO-NOVUM 10/11-21	ethinyl estradiol; norethindrone	TABLET;ORAL-21	018354-001	Jan 11, 1982		DISCN	Yes	No